1255099-67-2 Usage
Uses
Used in Pharmaceutical Industry:
3-(N-tert-butoxycarbonyl)amino-4-hydroxymethyl-N-benzyloxycarbonylpyrrolidine is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to be selectively functionalized and manipulated due to the presence of Boc and Cbz protecting groups. This allows for the development of new drugs with specific therapeutic properties.
Used in Organic Synthesis:
In the field of organic synthesis, 3-(N-tert-butoxycarbonyl)amino-4-hydroxymethyl-N-benzyloxycarbonylpyrrolidine is employed as a building block for constructing complex organic molecules. Its versatility and the presence of protecting groups make it a valuable component in the synthesis of a wide range of bioactive compounds.
Used in Chemical Research:
3-(N-tert-butoxycarbonyl)amino-4-hydroxymethyl-N-benzyloxycarbonylpyrrolidine is utilized as a research tool in chemical laboratories to explore new synthetic pathways and develop innovative methodologies. The selective functionalization capabilities provided by the Boc and Cbz protecting groups make it an essential compound for advancing chemical knowledge and techniques.
Check Digit Verification of cas no
The CAS Registry Mumber 1255099-67-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,5,0,9 and 9 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1255099-67:
(9*1)+(8*2)+(7*5)+(6*5)+(5*0)+(4*9)+(3*9)+(2*6)+(1*7)=172
172 % 10 = 2
So 1255099-67-2 is a valid CAS Registry Number.
1255099-67-2Relevant academic research and scientific papers
FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS
-
, (2011/05/06)
Disubstituted 3,8-diaza-bicyclo[4.2.0]octane and 3,6-diazabicyclo [3.2.0]heptane compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.
FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS
-
, (2011/05/06)
Certain disubstituted 3,8-diaza-bicyclo[4.2.0]octane and 3,6-diazabicyclo [3.2.0]heptane are described, which are useful as orexin inhibitors. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.
